fullerene c60 has been researched along with pyrazolanthrone in 1 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (pyrazolanthrone) | Trials (pyrazolanthrone) | Recent Studies (post-2010) (pyrazolanthrone) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 1,484 | 2 | 765 |
Protein | Taxonomy | fullerene c60 (IC50) | pyrazolanthrone (IC50) |
---|---|---|---|
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 20.2 | |
TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 6.31 | |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 0.72 | |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 8 | |
Dual specificity protein kinase TTK | Homo sapiens (human) | 0.8987 | |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | 0.921 | |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | 1.0111 | |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.957 | |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | 1.4193 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funakoshi-Tago, M; Kasahara, T; Mashino, T; Nagata, T; Nakamura, S; Tago, K; Tanaka, K; Tsukada, M | 1 |
1 other study(ies) available for fullerene c60 and pyrazolanthrone
Article | Year |
---|---|
Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway.
Topics: Amino Acid Substitution; Animals; Anthracenes; Apoptosis; Cell Line; Cell Transformation, Neoplastic; Fullerenes; Janus Kinase 2; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; MAP Kinase Kinase 7; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Proto-Oncogene Proteins c-myc; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2012 |